期刊文献+

铜绿假单胞菌耐药性临床分析

The clinical analysis of Drug resistance of pseudomonas aeruginosa.
暂未订购
导出
摘要 目的分析铜绿假单胞菌的耐药特点,指导临床用药。方法收集2005年1月至2006年12月南昌大学第一附属医院分离的189株铜绿假单胞菌,采用纸片扩散法进行药物敏感试验,数据分析采用 WHONET5.3软件。结果 189株铜绿假单胞菌分离株中,耐药率<30%的抗菌药物有哌拉西林/三唑巴坦、亚胺培南、头孢他啶、头孢吡肟和阿米卡星,其中对亚胺培南耐药率达到22.5%。结论铜绿假单胞菌耐药严重,医院应加强对铜绿假单胞菌的监测,临床要依据药敏试验结果合理用药。 Objective To investigate the antibiotic resistance of pseudomonas aeruginosa isolated from our hospital dur- ing Janury 2005 to December 2006.Methods Disc diffusion method was used to detemine the susceptibility of 189 strains of pseudomonas aeruginosa to 10 antibiotics,WHONET 5.3 was applied for analysis.Results Among 189 strains of pseudomonas aeruginosa,resistance rates to piperacillin-tazobactam,imipenem,ceftazidime,cefepime and amikacin were less than 30%.The resistance rate to imipenem reached 22.5%.Conclusion The drug resistance of PAE is seri- ous.Supervision of drug resistance of PAE should be strengthened in hospital.It's very important to select antibiotics correctly according to the results of susceptibility test in clinic.
作者 胡国信
出处 《中国实用内科杂志》 CAS CSCD 北大核心 2007年第S1期226-227,共2页 Chinese Journal of Practical Internal Medicine
关键词 铜绿假单胞菌 抗菌药物 耐药性 Pseudomonas aeruginosa Antibiotics Drug resistance
  • 相关文献

参考文献5

二级参考文献36

  • 1[1]CDC, National Nosocomial Infections Surveillance(NNIS) System report, Data summary from October 1986-April 1998; issyed June 1998[J]. Am J Infect Control, 1998,26: 522-533
  • 2[2]Gales AC, Jones RN, Turnidge J, et al. Characterization of Pseudomonas aeruginosa isolates: occurrence rates, antimicrobial susceptibility patterns, and molecular typing in the global SENTRY Antimicrobial Surveillance Program, 1997-1999[J].Clin Infect Dis,2001,32(Suppl 2): 146-155
  • 3[3]Harris AD, Smith D, Johnson JA, et al. Risk factors for imipenem-resistant pseudomonas aeruginosa among hospitalized patients [J]. Clin Infect Dis, 2002,34: 340-345
  • 4[4]Busher KH, Cullmann W, Dick W, et al. Imipenem resistance in pseudomonas aeruginosa resulting from diminished expression of an outer membrane protein[J]. Antimicrob Agents Chemother,1987,31 : 703-708
  • 5[5]Pai H, Kim J, Kim J, et al. Carbapenem resistance mechanisms in pseudomonas aeruginosa clinical isolates [J]. Antimicrob agents chemother,2001,45:480-484
  • 6Heydom A,Ersboll B,Kato J,et al.Statistical analysis of Pseudomonas aeruginosa biofilm development:impact of mutations in genes involved in twitching motility,cell-to-cell signaling,and stationary-phase sigma factor expression [J].Appl Envir Microbiol,200
  • 7Bagge N,Ciofu O,Hentzer M,et al.Constitutive high expression of chromosomal β-Lactamase in Pseudomonas aeruginosa caused by a new insertion sequence located in ampD [J] Antimicrob Agents Chemother ,2002,46 (11):3406
  • 8Mac Gowan AP,Bowker KE.Mechanism of fluoroquinolone resistance is an important factor in determining the antimicrobial effect of gemifloxacin against Streptococcus pneumoniae in an in vitro pharrnacokinetic model [J].Antimicrob Agents Chemother ,2003,47 (
  • 9Kureishi A,Diver JM,Beckthold B,et al.Cloning and nucleotide sequence of Pseudomonas aeruginosa gyrA gene from strain PAO1 and quinolone-resistant clinical isolates [J].Antimicrob Agents Chemother ,1994,38 (9):1944
  • 10Takenouchi T,Sakagawa E,Sugawara M.Detection of gyrA mutations among 335 Pseudomonas aeruginosa stains isolated in Japan and their susceptibilities to fluoroquinolones[J].Antimicrob Agents Chemother ,1999,43(2) :406

共引文献717

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部